How optimized LLMs are transforming drug development

Logo
Presented by

Chris McSpiritt, VP, Life Sciences Strategy, Domino Data Lab

About this talk

Large Language Models (LLMs) are transforming drug development by accelerating research, improving decision-making, and enhancing efficiencies across various process stages. However, to fully harness their potential, LLMs must be optimized for specific use cases and tailored to the unique needs of pharmaceutical organizations. Watch this session to discover how optimized LLMs can transform drug discovery, clinical trials, and regulatory processes by: 1. Reduce time to market by streamlining research and data analysis 2. Improve accuracy and compliance through tailored AI models 3. Enhance collaboration across research, clinical, and regulatory teams You’ll learn best practices for integrating LLMs into pharmaceutical workflows, ensuring compliance with regulatory frameworks, and optimizing AI models to drive innovation. Discover how leading organizations are leveraging AI to gain a competitive edge while maintaining efficiency and compliance.
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (14)
Subscribers (544)
Domino powers model-driven business for the world’s most advanced enterprises, including over 20% of the Fortune 100. Our Enterprise MLOps platform
speeds up the development and deployment of data science work while increasing collaboration and governance, to scale data science into a competitive
advantage. Our platform enables thousands of data scientists to develop better medicines, grow more productive crops, adapt risk models to major
economic shifts, build better cars, improve customer support, or simply recommend the best purchase to make at the right time.